Skip to main content
. 2016 Nov 8;11(11):e0165948. doi: 10.1371/journal.pone.0165948

Fig 12. Forest plot of the relative risks of adverse events in case group (lenalidomide 5 or 10mg/day) and control group (placebo).

Fig 12